Di Mola N, Bellasio E
Farmaco Sci. 1985 Jul;40(7):517-33. doi: 10.1002/chin.198546187.
A series of 6-substituted-N-(4H-1,2,4-triazol-4-yl)-3-pyridazinamines [(II), Scheme 1] and 3-substituted-6-(3,5-dimethyl-1H-1,2,4-triazol-1-yl) pyridazines [(XII), Scheme 3-5] were synthesized. The compounds were evaluated for their oral antihypertensive activity in rats (SHR) and only some compounds of structure (XII) induced a moderate decrease in systolic blood pressure.
合成了一系列6-取代-N-(4H-1,2,4-三唑-4-基)-3-哒嗪胺[(II),方案1]和3-取代-6-(3,5-二甲基-1H-1,2,4-三唑-1-基)哒嗪[(XII),方案3 - 5]。对这些化合物在大鼠(自发性高血压大鼠)中的口服抗高血压活性进行了评估,只有一些结构为(XII)的化合物引起收缩压适度下降。